Catalyst Wire Dossier Catalyst Wire Dossier

Pegvisomant (Somavert)

pegvisomant · Novo Nordisk
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Pegvisomant (Somavert), covering 2013-10-24 to 2013-12-13. Get the full timeline:

Most recent: Clinical Trial Update: Figitumumab Combined With Pegvisomant For Advanced Solid Tumors [Phase 1]

See pricing